Page last updated: 2024-08-16

tetraethylammonium and natriuretic peptide, c-type

tetraethylammonium has been researched along with natriuretic peptide, c-type in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Leeuw, PW; De Mey, JG; Houben, AJ; Kroon, AA; Smits, PA; van der Zander, K1
Cho, KW; Cui, X; Cui, YG; Guo, HS; Kim, SZ; Li, ZL; Xu, WX1

Other Studies

2 other study(ies) available for tetraethylammonium and natriuretic peptide, c-type

ArticleYear
Nitric oxide and potassium channels are involved in brain natriuretic peptide induced vasodilatation in man.
    Journal of hypertension, 2002, Volume: 20, Issue:3

    Topics: Adult; Cyclic GMP; Drug Combinations; Enzyme Inhibitors; Forearm; Humans; Male; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nitric Oxide; omega-N-Methylarginine; Potassium Channel Blockers; Potassium Channels; Regional Blood Flow; Tetraethylammonium; Vasodilation; Vasodilator Agents

2002
Inhibitory effect of C-type natriuretic peptide on spontaneous contraction in gastric antral circular smooth muscle of rat.
    Acta pharmacologica Sinica, 2003, Volume: 24, Issue:10

    Topics: Animals; Atrial Natriuretic Factor; Cyclic GMP; Female; Gastric Mucosa; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Potassium Channel Blockers; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Tetraethylammonium

2003